Larry Biegelsen
Stock Analyst at Wells Fargo
(3.82)
# 707
Out of 5,138 analysts
353
Total ratings
55.78%
Success rate
7.38%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Overweight | $160 → $145 | $97.57 | +48.61% | 15 | Jan 14, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $28 | $22.77 | +23.00% | 3 | Dec 12, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $114 → $139 | $105.35 | +31.94% | 8 | Dec 10, 2025 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $72 → $82 | $82.20 | -0.24% | 20 | Dec 5, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $96 | $84.32 | +13.85% | 18 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Overweight | $100 → $114 | $99.15 | +14.98% | 19 | Nov 19, 2025 | |
| SYK Stryker | Maintains: Overweight | $452 → $456 | $363.32 | +25.51% | 17 | Nov 14, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $16 → $17 | $17.46 | -2.63% | 9 | Nov 14, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $103 → $95 | $80.19 | +18.47% | 12 | Nov 14, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $13 → $14 | $21.10 | -33.65% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $9.85 | +1.52% | 15 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $93 | $69.34 | +34.12% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $113.09 | +7.88% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $87 | $82.92 | +4.92% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $124 → $125 | $90.10 | +38.73% | 15 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $539.32 | +11.25% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $170 → $212 | $219.30 | -3.33% | 14 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.23 | -30.89% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $79.44 | +17.07% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.86 | +61.73% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $20.38 | +17.79% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $351.48 | -17.49% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $13.84 | +4.77% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $88.98 | +10.14% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $17.18 | -1.05% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.76 | +284.01% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $123.76 | +9.89% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $93.55 | -25.17% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $208.54 | +29.47% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $65.54 | - | 2 | Nov 2, 2017 |
Inspire Medical Systems
Jan 14, 2026
Maintains: Overweight
Price Target: $160 → $145
Current: $97.57
Upside: +48.61%
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $22.77
Upside: +23.00%
Teleflex
Dec 10, 2025
Maintains: Equal-Weight
Price Target: $114 → $139
Current: $105.35
Upside: +31.94%
The Cooper Companies
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $82.20
Upside: -0.24%
Edwards Lifesciences
Dec 5, 2025
Maintains: Overweight
Price Target: $95 → $96
Current: $84.32
Upside: +13.85%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $99.15
Upside: +14.98%
Stryker
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $363.32
Upside: +25.51%
Bausch + Lomb
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.46
Upside: -2.63%
Merit Medical Systems
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $80.19
Upside: +18.47%
Tandem Diabetes Care
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $21.10
Upside: -33.65%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $9.85
Upside: +1.52%
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $69.34
Upside: +34.12%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $113.09
Upside: +7.88%
Oct 30, 2025
Maintains: Overweight
Price Target: $89 → $87
Current: $82.92
Upside: +4.92%
Oct 23, 2025
Maintains: Overweight
Price Target: $124 → $125
Current: $90.10
Upside: +38.73%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $539.32
Upside: +11.25%
Oct 3, 2025
Upgrades: Overweight
Price Target: $170 → $212
Current: $219.30
Upside: -3.33%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.23
Upside: -30.89%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $79.44
Upside: +17.07%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.86
Upside: +61.73%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $20.38
Upside: +17.79%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $351.48
Upside: -17.49%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $13.84
Upside: +4.77%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $88.98
Upside: +10.14%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $17.18
Upside: -1.05%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.76
Upside: +284.01%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $123.76
Upside: +9.89%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $93.55
Upside: -25.17%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $208.54
Upside: +29.47%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $65.54
Upside: -